Nasdaq Confirms OSR Health Stock Loyalty Program Will Not Cause Automatic Price Reductions
New York, Friday, 31 July 2026.
Nasdaq confirmed OSR Health’s loyalty program will not trigger automatic price drops, offering clarity to investors whose share positions could potentially expand up to sixfold as milestones are met.
Nasdaq Clarifies CVR Treatment for OSR Health
OSR Health, Inc. (NASDAQ: OSRH) announced on July 31, 2026, that it received verbal confirmation from the Nasdaq Stock Market regarding its Loyalty Contingent Value Right (CVR) program [1]. According to the communication, the implementation of the Loyalty CVR program will not result in a price adjustment for the company’s common stock, offering clarity to shareholders and market participants tracking the healthcare firm’s capital structure [1]. This determination specifically addresses mechanical price adjustments, such as ex-date downward adjustments, upon CVR distribution or delivery of additional shares [1]. The announcement provides significant structural clarity as the company moves forward with its shareholder loyalty initiatives [1].
Program Mechanics and Eligibility Timeline
To be eligible for the CVR program, shareholders must hold OSRH shares by the record date of 14 August 2026 and complete enrollment [1][2]. The program involves four measurement dates over the twelve months following 31 July 2026, where enrolled shareholders who hold shares continuously may receive additional shares at no cost if specific closing-price thresholds are met [1]. According to company communications, a shareholder’s position can grow up to 6 times as milestones are met [3]. The company has highlighted key dates including the 2026 Annual Meeting on August 7, 2026, and the CVR Record Date on August 14, 2026 [2].
Management Commentary and Strategic Focus
Peter Hwang, CEO of OSR Health, stated that the communication with Nasdaq provides clarity on an important structural question about the CVR Program [1]. He noted that investors who enroll and hold will receive additional shares, and the value of those shares will be determined entirely by the market’s assessment of what the company is building, not by any mechanical ex-date adjustment [1]. Tim Smith, Head of Investor Relations at OSR Health, emphasized that the priority is making enrollment as clear and straightforward as possible [1]. The company is currently focusing on streamlining the enrollment process for the Shareholder Loyalty CVR program to ensure eligible shareholders can access benefits if specific price milestones are achieved [1].